Lisata Therapeutics Inc (LSTA)
2.77
-0.04
(-1.60%)
USD |
NASDAQ |
May 17, 16:00
2.76
-0.01
(-0.36%)
After-Hours: 20:00
Lisata Therapeutics Total Assets (Quarterly): 48.24M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 48.24M |
December 31, 2023 | 54.69M |
September 30, 2023 | 58.09M |
June 30, 2023 | 62.36M |
March 31, 2023 | 66.33M |
December 31, 2022 | 73.03M |
September 30, 2022 | 78.53M |
June 30, 2022 | 85.88M |
March 31, 2022 | 91.46M |
December 31, 2021 | 97.01M |
September 30, 2021 | 102.54M |
June 30, 2021 | 108.61M |
March 31, 2021 | 114.61M |
December 31, 2020 | 36.00M |
September 30, 2020 | 42.02M |
June 30, 2020 | 37.48M |
March 31, 2020 | 22.14M |
December 31, 2019 | 27.15M |
September 30, 2019 | 31.67M |
June 30, 2019 | 36.35M |
March 31, 2019 | 41.29M |
December 31, 2018 | 44.58M |
September 30, 2018 | 47.85M |
June 30, 2018 | 52.09M |
March 31, 2018 | 56.72M |
Date | Value |
---|---|
December 31, 2017 | 63.38M |
September 30, 2017 | 67.56M |
June 30, 2017 | 72.25M |
March 31, 2017 | 48.53M |
December 31, 2016 | 53.51M |
September 30, 2016 | 57.28M |
June 30, 2016 | 56.71M |
March 31, 2016 | 63.18M |
December 31, 2015 | 57.21M |
September 30, 2015 | 119.70M |
June 30, 2015 | 128.62M |
March 31, 2015 | 118.81M |
December 31, 2014 | 126.28M |
September 30, 2014 | 131.34M |
June 30, 2014 | 133.40M |
March 31, 2014 | 86.39M |
December 31, 2013 | 89.82M |
September 30, 2013 | 57.79M |
June 30, 2013 | 53.61M |
March 31, 2013 | 49.90M |
December 31, 2012 | 54.41M |
September 30, 2012 | 128.81M |
June 30, 2012 | 138.03M |
March 31, 2012 | 167.28M |
December 31, 2011 | 155.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
22.14M
Minimum
Mar 2020
114.61M
Maximum
Mar 2021
63.71M
Average
60.23M
Median
Total Assets (Quarterly) Benchmarks
Becton Dickinson & Co | 54.16B |
Edwards Lifesciences Corp | 9.736B |
AIM ImmunoTech Inc | 19.38M |
Protalix BioTherapeutics Inc | 89.82M |
Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 5.497M |
Shareholders Equity (Quarterly) | 43.00M |